Jonathan E. Lim - Jul 20, 2021 Form 4 Insider Report for Erasca, Inc. (ERAS)

Role
Chairman and Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Ebun S. Garner, Attorney-in-Fact
Stock symbol
ERAS
Transactions as of
Jul 20, 2021
Transactions value $
$0
Form type
4
Date filed
7/20/2021, 08:58 PM
Previous filing
Jul 15, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERAS Common Stock Conversion of derivative security +5.14M +34.19% 20.2M Jul 20, 2021 By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005 F1, F2
transaction ERAS Common Stock Conversion of derivative security +5.44M +84.25% 11.9M Jul 20, 2021 By City Hill, LLC F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERAS Series A Preferred Stock Conversion of derivative security -6.16M -100% 0 Jul 20, 2021 Common Stock 5.14M $0.00 By the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005 F1, F2
transaction ERAS Series A Preferred Stock Conversion of derivative security -6.08M -100% 0 Jul 20, 2021 Common Stock 5.07M $0.00 By City Hill, LLC F1, F3
transaction ERAS Series B-1 Preferred Stock Conversion of derivative security -336K -100% 0 Jul 20, 2021 Common Stock 280K $0.00 By City Hill, LLC F1, F3
transaction ERAS Series B-2 Preferred Stock Conversion of derivative security -112K -100% 0 Jul 20, 2021 Common Stock 93.3K $0.00 By City Hill, LLC F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering.
F2 The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F3 Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.

Remarks:

Chairman and Chief Executive Officer